Ipratropium bromide dry-powder inhalation - Dura/Spiros

Drug Profile

Ipratropium bromide dry-powder inhalation - Dura/Spiros

Alternative Names: Ipratropium bromide Spiros; SCH 1000 dry-powder inhalation - Dura/Spiros

Latest Information Update: 13 Jul 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dura Pharmaceuticals; Spiros Development Corporation II
  • Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Chronic obstructive pulmonary disease

Most Recent Events

  • 07 Jul 2000 New profile
  • 07 Jul 2000 Discontinued-Unspecified Phase in Asthma in USA (Inhalation)
  • 07 Jul 2000 Discontinued-Unspecified Phase in Chronic obstructive pulmonary disease in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top